Multispectral and Molecular Docking Studies Reveal Potential Effectiveness of Antidepressant Fluoxetine by Forming π-Acceptor Complexes

Poor mood, lack of pleasure, reduced focus, remorse, unpleasant thoughts, and sleep difficulties are all symptoms of depression. The only approved treatment for children and adolescents with major depressive disorder (MDD) is fluoxetine hydrochloride (FXN), a serotonin selective reuptake inhibitor a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaber, Ahmed, Alsanie, Walaa F., Alhomrani, Majid, Alamri, Abdulhakeem S., Alyami, Hussain, Shakya, Sonam, Habeeballah, Hamza, Alkhatabi, Heba A., Felimban, Raed I., Alamri, Abdulwahab, Alhabeeb, Abdulhameed Abdullah, Raafat, Bassem M., Refat, Moamen S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505585/
https://www.ncbi.nlm.nih.gov/pubmed/36144618
http://dx.doi.org/10.3390/molecules27185883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505585/
https://www.ncbi.nlm.nih.gov/pubmed/36144618
http://dx.doi.org/10.3390/molecules27185883

Ejemplares similares